Getting Ready for the Bounce: Ionis Pharmaceuticals Inc (IONS) Stock
Wolfe Research raised the price target for the Ionis Pharmaceuticals Inc (NASDAQ:IONS) stock from “a Peer perform” to “an Outperform”. The rating was released on April 10, 2024, according to finviz. We previously noted in another research note published on January 02, 2024 by BofA Securities that upgraded the stock from a Neutral to a […]
Are you thinking about selling now? Ionis Pharmaceuticals Inc (IONS) Stock
Wolfe Research raised the price target for the Ionis Pharmaceuticals Inc (NASDAQ:IONS) stock from “a Peer perform” to “an Outperform”. The rating was released on Apr-11-24, according to finviz. We previously noted in another research note published on January 02, 2024 by BofA Securities that upgraded the stock from a Neutral to a Buy with […]
A healthy upside potential exists for Ionis Pharmaceuticals Inc (IONS) Stock
BofA Securities raised the price target for the Ionis Pharmaceuticals Inc (NASDAQ:IONS) stock from “a Neutral” to “a Buy”. The rating was released on January 02, 2024, according to finviz. We previously noted in another research note published on October 23, 2023 by BofA Securities that upgraded the stock from an Underperform to a Neutral […]
A positive surprise is on the way: Ionis Pharmaceuticals Inc (IONS) Stock
BofA Securities raised the price target for the Ionis Pharmaceuticals Inc (NASDAQ:IONS) stock from “a Neutral” to “a Buy”. The rating was released on January 02, 2024, according to finviz. We previously noted in another research note published on October 23, 2023 by BofA Securities that upgraded the stock from an Underperform to a Neutral […]
A New Look at Ionis Pharmaceuticals Inc (IONS) Stock’s Hidden Strategies
BofA Securities raised the price target for the Ionis Pharmaceuticals Inc (NASDAQ:IONS) stock from “a Neutral” to “a Buy”. The rating was released on January 02, 2024, according to finviz. We previously noted in another research note published on October 23, 2023 by BofA Securities that upgraded the stock from an Underperform to a Neutral […]
